Immediate Impact
2 by Nobel laureates 1 from Science/Nature 63 standout
Citing Papers
Lorlatinib Versus Crizotinib in Patients With Advanced ALK -Positive Non–Small Cell Lung Cancer: 5-Year Outcomes From the Phase III CROWN Study
2024 Standout
An Update on the Nitrogen Heterocycle Compositions and Properties of U.S. FDA-Approved Pharmaceuticals (2013–2023)
2024 Standout
Works of K. Park being referenced
Vandetanib in pretreated patients with advanced non-small cell lung cancer-harboring RET rearrangement: a phase II clinical trial
2016
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| K. Park | 171 | 113 | 102 | 14 | 229 | |
| Jiadi Gan | 174 | 164 | 88 | 18 | 278 | |
| Santosh Gupta | 151 | 115 | 72 | 15 | 231 | |
| Giovanni Burrafato | 135 | 153 | 63 | 13 | 238 | |
| S.-H.I. Ou | 121 | 125 | 106 | 16 | 292 | |
| Elisa Sottotetti | 103 | 178 | 98 | 21 | 276 | |
| Carminia M. Della Corte | 97 | 131 | 124 | 14 | 297 | |
| Shoujun Tang | 117 | 114 | 107 | 11 | 263 | |
| Susanna Aussó | 96 | 90 | 132 | 11 | 268 | |
| Christina J. Falcon | 205 | 174 | 95 | 22 | 285 | |
| Αναστασία Κατσιαμπούρα | 76 | 135 | 108 | 15 | 287 |
All Works
Loading papers...